Coenzyme Q10 is increased in placenta and cord blood during preeclampsia

被引:14
|
作者
Teran, Enrique
Vivero, Sandra
Racines-Orbe, Marcia
Castellanos, Alberto
Chuncha, Galo
Enriquez, Galo
Moya, Walter
机构
[1] Cent Univ Ecuador, Biomed Ctr, Expt Pharmacol & Cellular Metab Unit, Quito, Ecuador
[2] Hosp Gineco Obstet Isidro Ayora, Quito, Ecuador
关键词
Coenzyme Q(10); pregnancy; preeclampsia; placenta; cord blood;
D O I
10.1002/biof.5520250117
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Preeclampsia is a common (similar to 7% of all pregnancies) disorder of human pregnancy in which the normal hemodynamic response to pregnancy is compromised. Despite many years of intensive research, the pathogenesis of preeclampsia is still not fully understood. The objective of the present study was to investigate the levels of coenzyme Q(10) (CoQ(10)) in placental tissue compared to maternal and umbilical cord levels both during normal pregnancy and in those complicated with preeclampsia. Pregnant women (n = 30) and women with preeclampsia (n = 30) were included. Maternal, newborn cord blood levels and placental content of coenzyme Q(10) were measured by high performance liquid chromatography (HPLC). Plasma coenzyme Q(10) levels were significantly higher in normal pregnant women than in women with preeclampsia. CoQ(10) content in placenta from women with preeclampsia (mean 0.28 SEM 0.11 nmol/mg protein) was significantly higher compared to normal pregnancy (mean 0.09 SEM 0.01 nmol/mg protein; p = 0.05). Levels of CoQ(10) in cord blood from normal pregnant women (mean 0.30 SEM 0.05 mu mol/l) were significantly lower than in preeclamptic women (mean 4.03 SEM 2.38 mu mol/l). In conclusion, these data indicate a possible involvement of CoQ10 in preeclampsia that might bear deep physiopathological significance and deserve to be further elucidated.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 50 条
  • [31] Coenzyme Q10 protects kidney during ESWL
    Sarah Payton
    Nature Reviews Urology, 2013, 10 (12) : 676 - 676
  • [32] Pharmacokinetics of Coenzyme Q10
    Kalenikova, E. I.
    Gorodetskaya, E. A.
    Medvedev, O. S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 146 (03) : 313 - 316
  • [33] Statins and coenzyme Q10
    Ellis, CJ
    Scott, R
    LANCET, 2003, 361 (9363): : 1134 - 1135
  • [34] The Synthesis of Coenzyme Q10
    Luo, Meng
    Yang, Xuan
    Hu, Jiaoyang
    Ruan, Xin
    Mu, Fansong
    Fu, Yujie
    CURRENT ORGANIC CHEMISTRY, 2017, 21 (06) : 489 - 502
  • [35] Mutagenicity of coenzyme Q10
    Ikeda, K
    Suzuki, Y
    Yoshimura, I
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2005, 51 (01) : 45 - 47
  • [36] Plasma coenzyme Q10 levels following supplementation with various coenzyme Q10 products
    Bhagavan, Hemmi N.
    Chopra, Raj K.
    FASEB JOURNAL, 2009, 23
  • [37] Relative bioavailabilities of coenzyme Q10 (ubiquinone) and reduced coenzyme Q10 (ubiquinol) formulations
    Bhagavan, HN
    Chopra, RK
    FASEB JOURNAL, 2004, 18 (04): : A150 - A150
  • [38] Development of Nanoparticulate Formulation of Coenzyme Q10 and Comparison of Plasma Coenzyme Q10 Response in a Single Supplementation with Regular Coenzyme Q10 Using Rats
    Ok, Hyang-Mok
    Kim, Sang-Mi
    Park, Joo-Won
    Kim, Kab-Sig
    Nam, Han-Kyul
    Kim, Ji Yeon
    Kwon, Oran
    JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY, 2012, 55 (05): : 619 - 623
  • [39] DEFICIENCY OF COENZYME Q10 IN HYPERTENSIVE RATS AND REDUCTION OF DEFICIENCY BY TREATMENT WITH COENZYME Q10
    IWAMOTO, Y
    YAMAGAMI, T
    FOLKERS, K
    BLOMQVIST, CG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 58 (03) : 743 - 748
  • [40] Development of nanoparticulate formulation of coenzyme Q10 and comparison of plasma coenzyme Q10 response in a single supplementation with regular coenzyme Q10 using rats
    Hyang-Mok Ok
    Sang-Mi Kim
    Joo-Won Park
    Kab-Sig Kim
    Han-Kyul Nam
    Ji Yeon Kim
    Oran Kwon
    Journal of the Korean Society for Applied Biological Chemistry, 2012, 55 : 619 - 623